Intraocular penetration of systemically administered antifungal agents
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 4 (2), 131-134
- https://doi.org/10.3109/02713688508999978
Abstract
Amphotericin B, 5-flucytosine (5-FC), and ketoconazole levels were estimated in vitreous and aqueous samples taken from four patients undergoing therapeutic vitrectomy for fungal endophthalmitis. The levels of amphotericin B in the vitreous of three patients were low (.04–.17 µg/ml). However, 5-FC was present in a concentration of 22.2 µg/ml in one patient. In another case the aqueous level of ketoconazole was 0.35 µg/ml. The vitreous in the same patient contained 0.71 µg/ml of the drug.This publication has 11 references indexed in Scilit:
- Interaction of Plasma Proteins and Lipoproteins with Amphotericin BThe Journal of Infectious Diseases, 1984
- The Avulsed Retinal Vessel Syndrome and Its VariantsOphthalmology, 1984
- Oral Ketoconazole Therapy for KeratomycosisAmerican Journal of Ophthalmology, 1983
- Disposition of ketoconazole, an oral antifungal, in humansAntimicrobial Agents and Chemotherapy, 1982
- Miconazole Therapy for KeratomycosisAmerican Journal of Ophthalmology, 1981
- Pharmacokinetics of amphotericin B and flucytosinePublished by Oxford University Press (OUP) ,1979
- Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugsPostgraduate Medical Journal, 1979
- Simple Assay for 5-Fluorocytosine in the Presence of Amphotericin BAntimicrobial Agents and Chemotherapy, 1976
- Bioassay for Hamycin and Amphotericin B in Serum and Other Biological FluidsApplied Microbiology, 1969
- Ocular Penetration of Amphotericin BArchives of Ophthalmology (1950), 1965